Pharma Industry

Coronary Heart Disease & Statins Controversy (Part III) – Blog Post by Asrar Qureshi

Dear Colleagues! Today is Pharma Veterans Blog Post #179. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to…

Coronary Heart Disease, Statins & Mediterranean Diet (Part I) – Blog Post by Asrar Qureshi

Dear Colleagues! Today is Pharma Veterans Blog Post #177. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to…

January 2019 Price Increase for Pharmaceutical Industry – Blog Post by Asrar Qureshi

Commentary on Jan 2019 Drug Prices Increase and Public Sentiment

The Importance of Internship in Corporate Setting – Blog Post by Hasan Jamal

Dear Colleagues! Pharma Veterans Blog Post #175 is being republished The earlier one was somehow published incomplete. Inconvenience is regretted. Pharma Veterans shares the wealth of knowledge and wisdom of…

The Importance of Internship in Corporate Setting – Blog Post by Hasan Jamal

Posted on January 25, 2019January 25, 2019
No comments
byAsrar Qureshi

Dear Colleagues! Today is Pharma Veterans Blog Post #175. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to…

Fluoroquinolones Safety Concerns and Warnings (Part II) – Blog Post by Asrar Qureshi

Dear Colleagues! Today is Pharma Veterans Blog Post #174. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to…

View Post

574
3 min

Coronary Heart Disease & Statins Controversy (Part III) – Blog Post by Asrar Qureshi

Coronary Heart Disease, Statins & Mediterranean Diet (Part I) – Blog Post by Asrar Qureshi

January 2019 Price Increase for Pharmaceutical Industry – Blog Post by Asrar Qureshi

The Importance of Internship in Corporate Setting – Blog Post by Hasan Jamal

The Importance of Internship in Corporate Setting – Blog Post by Hasan Jamal

Fluoroquinolones Safety Concerns and Warnings (Part II) – Blog Post by Asrar Qureshi

Evolution of Generic Pharmaceutical Industry in Pakistan (Part V) – Blog Post by Asrar Qureshi

Evolution of Generic Pharmaceutical Industry in Pakistan (Part IV) – Blog Post by Asrar Qureshi

Evolution of Generic Pharmaceutical Industry in Pakistan (Part III) – Blog Post by Asrar Qureshi

Generic Pharmaceutical Industry in Pakistan (Part II) – Blog Post by Asrar Qureshi